This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Baillargeon JP (2005) Use of insulin sensitizers in polycystic ovarian syndrome. Curr Opin Investig Drugs 6: 1012–1022
Palomba S et al. (2005) Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 90: 4068–4074
Legro RS et al. (2007) Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 356: 551–566
Kashyap S et al. (2004) Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome. Hum Reprod 19: 2474–2483
Baillargeon JP et al. (2004) Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. Fertil Steril 82: 893–902
Acknowledgements
The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Pesant, MH., Baillargeon, JP. Ovulation induction in polycystic ovary syndrome—how do metformin and clomifene citrate compare?. Nat Rev Endocrinol 3, 512–513 (2007). https://doi.org/10.1038/ncpendmet0529
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0529